Biji pasar: Actuate Therapeutics Inc. (ACTU)

The market trend for Actuate Therapeutics, Inc. (ACTU) shares, recorded at 0.01, is driven by a production outsourcing model that eliminates unnecessary infrastructure costs. Growth is supported by exclusive patents targeting resistance in brain and pancreatic tumors. Looking ahead, Actuate Therapeutics, Inc. (ACTU) plans the global rollout of elraglusib, leveraging Phase II test results to expand its presence in the oncology sector.

ACTU (actuatetherapeutics.com) riwayat Kapitalisasi pasar saka 14.08.2024 nganti 22.10.2026

Rincian metrik lan analitis perusahaan Actuate Therapeutics Inc (ACTU)

Actuate Therapeutics, Inc. (ACTU): dhaptar indikator lan metrik:

Rega saham Actuate Therapeutics|ACTU - Target konsensus|Biji pasar Actuate Therapeutics Inc

Pambiji fundamental perusahaan:Actuate Therapeutics ACTU

Sampel barang Actuate Therapeutics, Inc.

Market capitalization aggregates the value of all shares, reflecting the current investor consensus regarding the enterprise's total assets. This indicator measures institutional demand through the lens of market pricing. Analyzing the issuer's market value reveals that the valuation of Actuate Therapeutics, Inc. (ACTU) depends on the prospects of the GSK-3 inhibitor. Fluctuations in this metric signal a reassessment of the drug's clinical trial risks. The trend of this indicator determines the company's investment attractiveness within the biotechnology sector.

Pesaing Actuate Therapeutics, Inc. (ACTU)

Kapitalisasi pasar ONC (BeiGene)|HALO - Biji pasar|RVMD: Biji pasar|Ascentage Pharma Corp - Nilai pasar|CGON (CG Oncology, Inc.) - Biji pasar|urogen.com (URGN) - Kapitalisasi pasar|BCAX (Bicara Therapeutics) - Kapitalisasi pasar|Biji pasar Personalis Inc (PSNL)|Kapitalisasi pasar ERAS|Kapitalisasi pasar Delcath Corp (DCTH)|Nilai pasar Y-mAbs Therapeutics YMAB|AURA: Kapitalisasi pasar|Candel - Kapitalisasi pasar|Accuray Inc (ARAY) - Biji pasar|SLS: Kapitalisasi pasar|Nilai pasar Citius Oncology Inc (CTOR)|Nilai pasar TuHURA Biosciences Inc.|TARA: Nilai pasar|Biji pasar FATE (Fate Therapeutics)|WHWK (aadibio.com) - Nilai pasar|Kapitalisasi pasar TCRX (TScan Therapeutics, Inc.)|CSBR - Biji pasar|XBIT: Biji pasar|CVM - Kapitalisasi pasar|OS Therapies (OSTX) - Nilai pasar|Radiopharm Theranostics Ltd - Nilai pasar|ARTV (Artiva Biotherapeutics Inc.) - Kapitalisasi pasar|Nilai pasar Adlai Nortye Limited ANL|Kapitalisasi pasar VERU|Kapitalisasi pasar tempesttx.com (TPST)|Kapitalisasi pasar XLO (Xilio Therapeutics)|RENB - Biji pasar|MURA: Biji pasar|Kairos Pharma Ltd - Nilai pasar|OKUR (onkuretherapeutics.com) - Biji pasar|CytoMed Therapeutics Limited (GDTC) - Kapitalisasi pasar|CRIS (Curis Inc.) - Kapitalisasi pasar|Kapitalisasi pasar Apollomics Corp|Biji pasar THAR (Tharimmune Corp)|Nilai pasar ADVB|Kapitalisasi pasar GNPX (Genprex, Inc.)|Calidi Biotherapeutics Inc. (CLDI) - Nilai pasar|SBFM: Biji pasar|Nilai pasar XBIO (Xenetic Biosciences)|SLRX (Salarius) - Biji pasar|PPBT: Nilai pasar|AONC (American Oncology Network Inc) - Kapitalisasi pasar|BGNE: Nilai pasar|Kapitalisasi pasar CKPT|ELEV - Nilai pasar|Nilai pasar iCAD ICAD|Nilai pasar IKNA|Notable Labs, Ltd. - Kapitalisasi pasar|VIRX - Kapitalisasi pasar|MorphoSys (MOR) - Nilai pasar|Biji pasar NAYA (NAYA Biosciences Inc)|AAPGV (Ascentage Pharma Group Ltd) - Kapitalisasi pasar